Otto C. Boerman

Bucknell University — United States

Medicine · Health Sciences

86h-index27.8kcitations683works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(261), Monoclonal and Polyclonal Antibodies Research(117), Medical Imaging Techniques and Applications(96), Renal cell carcinoma treatment(65), Orthopedic Infections and Treatments(58)

Publications682 total

Optimization of Seeding Protocol for Three-Dimensional Vascular Network in a Commercial Collagen Scaffold

SSRN Electronic Journal·2025Open Access

Supplemental Table 2 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Supplementary Tables S1-S4 and Supplementary Figures S1-S12 from Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways

2023Open Access

Supplemental Table 2 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Data from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Data from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Supplemental Figure 3 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Supplemental Figure 1 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Supplemental Figure 2 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Supplemental Figure 2 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Data from Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways

2023Open Access

Supplemental Figure 3 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Data from Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways

2023Open Access

Supplemental Table 1 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Supplemental Table 1 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Supplemental Figure 1 from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

2023Open Access

Figure S6 from Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study

2023Open Access

Figure S2 from Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study

2023Open Access

Video S1 from Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study

2023Open Access

page 1 of 35Next →

Frequent Co-authors

Wim J.G. Oyen(33), Frans H.M. Corstens(11), Martin Gotthardt(10), Carl G. Figdor(9), Gosse J. Adema(8), Peter Laverman(7), I. Jolanda M. de Vries(6), Cornelis J.A. Punt(6), Cathelijne Frielink(6), Marion de Jong(6), W. Joost Lesterhuis(5), Maarten Brom(5), Ingrid Dijkgraaf(4), Sandra Heskamp(4), John A. Jansen(4), Nicole M. Scharenborg(3), Erik H.J.G. Aarntzen(3), Marleen Melis(3), Sander C.G. Leeuwenburgh(3), Egbert Oosterwijk(3)